Basic information Safety Related Supplier

ChemicalBook Product Catalog (±)-Amiflamine

1/1

(±)-Amiflamine NEW

$46.00 5mg

$71.00 10mg

$119.00 25mg

Min. Order
Purity≥98%
Cas No77502-96-6
Supply Ability10g
Update time2024-11-19

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

5YR

United States

show more

Chemical Properties

Product Name	(±)-Amiflamine
CAS No	77502-96-6
EC-No
Min. Order
Purity	≥98%
Supply Ability	10g
Release date	2024/11/19

Product Introduction

Bioactivity

Name	(±)-Amiflamine
Description	(±)-Amiflamine (2-dimethylphenethylamine) is an inhibitor of reversible MAO-A.
In vitro	The ex vivo approach was found to be valid for moclobemide in brain and liver and for cimoxatone in brain tissue;a slight underestimation of the MAO A inhibitory effect of the latter in the liver is likely.Definite underestimation occurred with (±)-Amiflamine in both tissues.Kinetic investigations using homogenates from pretreated rats showed (±)-Amiflamine to be a competitive inhibitor;cimoxatone was competitive in the liver but showed a more complex pattern in the brain.Moclobemide was noncompetitive in both tissues, as has been shown previously for brofaremine.Moclobemide prevented the deamination of dopamine and serotonin released from their striatal stores by tetrabenazine nearly as efficiently as clorgyline at an otherwise equieffective dose;cimoxatone was somewhat less effective relative to the reference compound, as was brofaremine, which was however given at a more effective dose.(±)-Amiflamine was much less effective than clorgyline at protecting dopamine, but equieffective with respect to serotonin[1].
In vivo	(±)-Amiflamine was 3 times less potent within noradrenergic neurons than within serotonergic neurons. A brain to plasma ratio of about 20:1 was found for (±)-Amiflamine and its metabolites. The plasma and the brain concentrations of the N-demethylated metabolite [FLA 788(+)] exceeded that of (±)-Amiflamine after a single dose, whereas the N,N-demethylated [FLA 668(+)] was found in low concentrations. The effect on MAO-A correlated significantly with the plasma and the brain concentration of FLA 788(+)[2].
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 32.5 mg/mL (169 mM)
Keywords	Monoamine Oxidase \| MAO \| Inhibitor \| inhibit \| FLA-336 \| FLA336 \| FLA 336 \| (±)-Amiflamine \| (±)Amiflamine \| (±) Amiflamine
Inhibitors Related	Hydroxyamine hydrochloride \| Hydralazine hydrochloride \| Rosmarinic acid \| Safinamide \| Azure B \| 1,4-Naphthoquinone \| Paeonol \| Isatin \| Methylene Blue \| Methylene Blue trihydrate \| Furazolidone \| Allylthiourea
Related Compound Libraries	Anti-Neurodegenerative Disease Compound Library \| Bioactive Compound Library \| Antidepressant Compound Library \| Neuronal Signaling Compound Library \| Inhibitor Library \| Mitochondria-Targeted Compound Library \| Anti-Aging Compound Library \| Bioactive Compounds Library Max \| Anti-Metabolism Disease Compound Library

show more

Company Profile Introduction

You may like

Recommended supplier

MSDS|CAS|CAS DataBase|Pricacy|Terms|About Us|New Products| Contact us|Computer Version
Chemical Book